Ribosomally synthesized and post-translationally modified
peptides
(RiPPs) are natural products with remarkable chemical and functional
diversities. These peptides are often synthesized as signals or antibiotics
and frequently associated with quorum sensing (QS) systems. With the
increasing number of available genomes, many hitherto unseen RiPP
biosynthetic pathways have been mined, providing new resources for
novel bioactive compounds. Herein, we investigated the underexplored
biosynthetic potential of Streptococci, prevalent
bacteria in mammal–microbiomes that include pathogenic, mutualistic,
and commensal members. Using the transcription factor-centric genome
mining strategy, we discovered a new family of lanthipeptide biosynthetic
loci under the control of potential QS. By in vitro studies, we investigated the reaction of one of these lanthipeptide
synthetases and found that it installs only one lanthionine moiety
onto its short precursor peptide by connecting a conserved TxxC region.
Bioinformatics and in vitro studies revealed that
these lanthipeptide synthetases (class VI) are novel lanthipeptide
synthetases with a truncated lyase, a kinase, and a truncated cyclase
domain. Our data provide important insights into the processing and
evolution of lanthipeptide synthetase to tailor smaller substrates.
The data are important for obtaining a mechanistic understanding of
the post-translational biosynthesis machinery of the growing variety
of lanthipeptides.